Müller-Werdan U - Search Results

1

ACE-inhibitor therapy and survival among patients with multiorgan dysfunction syndrome (MODS) of cardiac and non-cardiac origin.

Schmidt H, Hoyer D, Rauchhaus M, Prondzinsky R, Hennen R, Schlitt A, Carter J, Hottenrott K, Müller-Werdan U, Werdan K, Buerke M. Schmidt H, et al. Int J Cardiol. 2010 Apr 30;140(3):296-303. doi: 10.1016/j.ijcard.2008.11.104. Epub 2009 Jan 21. Int J Cardiol. 2010. PMID: 19157589

2

[Circulatory shock. Extrapulmonary etiology of respiratory insufficiency].

Vogelmeier C, Müller-Werdan U, Werdan K. Vogelmeier C, et al. Internist (Berl). 1995 Aug;36(8):756-64. Internist (Berl). 1995. PMID: 7558694 Review. German. No abstract available.

3

Xenoreactive natural antibodies and induced antibodies--their effects of beating cardiomyocytes as a model of a xenograft.

Müller-Werdan U, Koidl B, Autenrieth A, Klein D, Werdan K, Hammer C. Müller-Werdan U, et al. Mol Cell Biochem. 1996 Jul-Aug;160-161:315-23. doi: 10.1007/BF00240065. Mol Cell Biochem. 1996. PMID: 8901489

4

Elucidating molecular mechanisms of septic cardiomyopathy--the cardiomyocyte model.

Werdan K, Müller-Werdan U. Werdan K, et al. Mol Cell Biochem. 1996 Oct-Nov;163-164:291-303. doi: 10.1007/BF00408670. Mol Cell Biochem. 1996. PMID: 8974069 Review.

5

Partial inhibition of protein synthesis by Pseudomonas exotoxin A deranges catecholamine sensitivity of cultured rat heart myocytes.

Müller-Werdan U, Pfeifer A, Hübner G, Seliger C, Reithmann C, Rupp H, Werdan K. Müller-Werdan U, et al. J Mol Cell Cardiol. 1997 Feb;29(2):799-811. doi: 10.1006/jmcc.1996.0324. J Mol Cell Cardiol. 1997. PMID: 9140836

6

[The heart in infection and MODS (multiple organ dysfunction syndrome)].

Müller-Werdan U, Prondzinsky R, Witthaut R, Stache N, Heinroth K, Kuhn C, Schmidt H, Busch I, Werdan K. Müller-Werdan U, et al. Wien Klin Wochenschr. 1997;109 Suppl 1:3-24. Wien Klin Wochenschr. 1997. PMID: 9173672 Review. German.

7

[Systemic inflammatory reactions to extracorporeal therapy measures (II): Cardiopulmonary bypass].

Prondzinsky R, Müller-Werdan U, Pilz G, Witthaut R, Stabenow I, Werdan K, Zerkowski HR. Prondzinsky R, et al. Wien Klin Wochenschr. 1997 May 23;109(10):346-53. Wien Klin Wochenschr. 1997. PMID: 9265385 Review. German.

8

[Anaphylactic shock].

Müller-Werdan U, Werdan K. Müller-Werdan U, et al. Anaesthesist. 1997 Jun;46(6):549-63. doi: 10.1007/s001010050436. Anaesthesist. 1997. PMID: 9297387 Review. German. No abstract available.

9

Tumor necrosis factor alpha (TNF alpha) is cardiodepressant in pathophysiologically relevant concentrations without inducing inducible nitric oxide-(NO)-synthase (iNOS) or triggering serious cytotoxicity.

Müller-Werdan U, Schumann H, Fuchs R, Reithmann C, Loppnow H, Koch S, Zimny-Arndt U, He C, Darmer D, Jungblut P, Stadler J, Holtz J, Werdan K. Müller-Werdan U, et al. J Mol Cell Cardiol. 1997 Nov;29(11):2915-23. doi: 10.1006/jmcc.1997.0526. J Mol Cell Cardiol. 1997. PMID: 9405166

10

Endotoxin and tumor necrosis factor alpha exert a similar proinflammatory effect in neonatal rat cardiomyocytes, but have different cardiodepressant profiles.

Müller-Werdan U, Schumann H, Loppnow H, Fuchs R, Darmer D, Stadler J, Holtz J, Werdan K. Müller-Werdan U, et al. J Mol Cell Cardiol. 1998 May;30(5):1027-36. doi: 10.1006/jmcc.1998.0667. J Mol Cell Cardiol. 1998. PMID: 9618243

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

186 results

Search Page

Filters